What are new treatment options for newly-diagnosed multiple myeloma patients? Dr. Paul G. Richardson

How do I treat patients who have relapsed after quadruplet regimen in the first-line in MM?Подробнее

Triplet Therapy Determination Phase 3 Trial | Paul Richardson, MD | ASH 2023Подробнее

Dr. Paul G. Richardson Provides Study Updates on the Phase 3 DETERMINATION Trial for NDMM patientsПодробнее

Advances in Myeloma Treatments: What Patients & Caregivers Need to KnowПодробнее

Future Directions for Novel and Next Generation Therapy in Multiple Myeloma | Dana-FarberПодробнее

Novel therapeutic options and quadruplet regimens for newly diagnosed multiple myelomaПодробнее

New Directions in Treating Multiple Myeloma in the Era of Novel AgentsПодробнее

Paul Richardson | EBMT 2019 | Treatment options for transplant ineligible patients with NDMMПодробнее

Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer InstituteПодробнее

2019 Multiple Myeloma Symposium | Novel and Next Generation TherapyПодробнее

New Options To Treat Newly Dx, Relapsed Myeloma — Dr. Paul Richardson | MCRT Webcast July 11Подробнее